HENRY FORD HEALTH
SYSTEM |
One
Ford Place Suite 3A Detroit, MI 48202 (313) 874-5454 (phone) (313) 874-7137 (fax) |
|
|
2008 Annual Research Report NEW AWARDS High Value Health Care: A Strategy for the Quality Alliance Steering Committee P.I. David Nerenz, Ph.D. Funding Source: Brookings Institute Funding Amount: $27,201
This project will provide consultation services and assist project staff in designing and executing activities intended to measure and address ethnic/racial health disparities across the United States. The specific activity to be carried out at HFHS is analysis of data on workplace absenteeism and productivity as a function of health care disparities in a large, multi-employer data set.
Increasing Colorectal Cancer Screening in African Americans: Tailoring and Motivational Interviewing P.I.: Vic Strecher, Ph.D. (University of Michigan) Site P.I.: Jennifer Elston Lafata, Ph.D. Funding Source: NIH Funding Amount: $687,916 (total cost)
This project will focus on how the optimal use of tailored communications has the potential to change fundamentally how we communication with diverse populations.
Renal Function, Treatment Patterns, Resource Utilization and Outcomes in Acute Decompensated Heart Failure Patients Admitted in Hospital P.I.: David Lanfear, MD; Co-Investigator: Keoki Williams, MD, MPH Funding Source: Merck Funding Amount: $239,460 (total cost)
This project will estimate prevalence of renal impairment and level of renal impairment in actuate heart failure patients admitted into hospital, examine the frequency and magnitude of worsening renal function in acute heart failure patients in hospital and the relationship between worsening renal function and treatment pattern in the hospital. It will also determine whether worsening renal function in patients with acute health failure is associated with greater in-hospital resource utilization including length of stay, likelihood of an ICU stay, and time of ICU stay and determine whether worsening renal function in patients with acute heart failure is associated with increased hospitalization or death.
CANCORS Year 8 Site PI: David Nerenz, Ph.D. Funding Source: NIH/NCI (Subcontract from Dana Farber Cancer Institute) Funding Amount: $105,000 (total cost)
This project will continue analyses and write manuscripts, primarily on the topic of racial/ethnic disparities in lung cancer treatment. This work will focus primarily on determining how many patient in the current cohort are still alive and receiving care in the Henry Ford System in preparation for submission of a completing renewal application.
Race and Patient Perspectives on Use of Chemotherapy – Focus Groups P.I.: Arden Morris, MD (University of Michigan) Site P.I.: Jennifer Elston Lafata, Ph.D., Co-Investigator: Gwen Alexander, Ph.D Funding Source: University of Michigan Funding Amount: $7,200 (total cost)
This focus group project and semi-structured interview study will examine racial differences in patient perceptions and experiences with use or no-use of adjuvant therapy for colon cancer.
*Note: These projects are based and administered by other HFHS Departments, but are staffed by a CHSR Co-investigator(s).
PROPOSALS SUBMITTED (PENDING OR /NOT FUNDED) Pharmacogenomics of Inhaled Corticosteroid Responsiveness in Patients with Asthma P.I.: Keoki Williams, MD, MPH Funding Source: NIH Funding Amount: $3,634,668 Submitted: 10/5/07; Resubmitted 7/5/08 Status: Pending Award
African American patients, in particular, appear less likely to respond to corticosteroid therapy when compared with white patients. However, it is not currently known whether this difference results from genetic or environmental factors, or whether differences exist in inhaled steroid responsiveness (i.e., the recommended route of therapy). This question is of particular importance, since African American patients suffer disproportionately from asthma-related complications. In this proposal we plan to assess inhaled corticosteroid responsiveness by measuring change in FEV1 among both African American and white patients with asthma following 6 weeks of inhaled beclomethasone diproprionate treatment. This study group will also serve to identify genetic loci associated with ICS responsiveness. Participant DNA will be genotyped using genome-wide SNP arrays. The subsequent association analyses will use common and novel techniques to account for underlying population structure, such as genomic control, principle components analysis, and admixture mapping.
Lung/Colon Cancer Outcomes – Cancer Research Network (Years 9-11) P.I.: David Harrington, MD Site P.I.: David Nerenz, Ph.D. Funding Source: NCI Funding Amount: $193,697 Submitted: 11/25/08 Status: Pending
The overall objectives for the CanCORS renewal include: an understanding of the longer-term health outcomes for patients enrolled in the two CanCORS cohorts, approximately 5-7 years post-diagnosis. This additional analysis is necessary to fully characterize the impact of initial cancer care (that was evaluated in the previous funding cycle). In addition, disparities in health outcomes and factors that are likely to mediate such disparities will be evaluated. Additionally, an assessment of the quality of follow-up care delivered to patients beyond the initial acute treatment phase will be completed.
**Wayne State University - Henry Ford Health System Detroit Regional Institute for Clinical and Translational Research (DRICTR) PI: Michael Diamond, M.D. (Wayne State University) PI of TRIP Section and Co-Investigator: David R. Nerenz, Ph.D. Funding Source: NIH Funding Amount: $24,350,957 (total cost - entire project) $1,597,539 (TRIP section total cost) Status: Pending
The application is a response to an RFA to establish Clinical and Translational Science Award (CTSA) programs and centers. The grant is fundamentally an infrastructure grant to create a major overhaul of the support infrastructure for clinical and translational research. The WSU-HFHS application is a collaborative effort involving multiple faculty members or investigators from both institutions. Dr. Nerenz served as one of the five members of the application's Executive Committee and as the leader of the Translating Research Into Practice (TRIP) section of the application.
Time Allocated to Mental Health in Primary Care Visits P.I.: Ming Tai-Seale, MD (Texas A&M) Site P.I.: Jennifer Elston Lafata, Ph.D. Funding Source: NIH HFHS Funding Amount: $504,104 (total cost) Status: Not Funded
The main goal is to conduct a comprehensive analysis of the factors influencing primary care physicians’ allocation of clinical time and how well that time is used to assess and treat older adults with mental illnesses. The long-term objectives of this project are to inform policy and clinical practice so that more efficient and equitable mechanisms of financing and organization of mental health services in primary care can be developed.
Surveillance Care Decision-Making among Colorectal Cancer Survivors P.I.: Jennifer Elston Lafata, Ph.D. Funding Source: NCI Funding Amount: $2,165,641(total cost) Submitted: 6/06; Resubmitted: 3/19/08 (not funded – score 190); Resubmitted: 11/08 Status: Not Funded
The overall objective of this proposal is twofold. First, we will describe the quality of the surveillance care decision-making process among colorectal cancer survivors, both overall and by patient-defined subgroups. Second, we will examine the extent to which variation in surveillance care use is a result of an informed decision-making process and reflective of patient preferences.
Measuring and Reporting Health Care Outcomes in Vulnerable Populations: Should We Adjust for Sociodemographic Characteristics? PI: David Nerenz, Ph.D. Funding Source: Robert Wood Johnson Funding Amount: $310,000 (total cost) Submitted: 7/25/08 Status: Not Funded
The overall goal of the project is to identify, compare, and evaluate alternative ways to take sociodemographic factors (e.g., race/ethnicity, SES, primary language, literacy level) into account when measuring, analyzing, or publicly reporting health care outcome data.
The Delivery of Preventive Health Services during Annual Health Maintenance Exams. A Proposed Supplement to 1R01CA112379-01A1 P.I.: Jennifer Elston Lafata, Ph.D. Funding Source: NCI Funding Amount: $23,880 Submitted: 4/25/08 Status: Not Funded
This project will compile additional data to put the provision of counseling, immunization and screening services in context and to conduct new analyses in support of a manuscript that describes the provision of preventive health services more generally during annual HME’s in which an electronic medical record prompt is available, and determine which United States Preventive Services Task Force recommended screening and other services for which patient is due at time of visit.
Effective Communication for Preventing and Responding to Oncology Adverse Events P.I.: Tom Gallagher, MD (Washington University) Site P.I.: Jennifer Elston Lafata, Ph.D. Co-Investigator: Gwen Alexander, Ph.D Funding Source: ACS Funding Amount: $372,208 (total cost) Submitted 3/21/08 Status: Not Funded
The goal of this project is to improve patient-centered communication around adverse events and errors in cancer care. The aims of the project are to describe patient and provider experiences with communication around adverse events and errors in cancer care, to develop provider training materials and patient education materials for improving communication around adverse events and errors in cancer care, and to dissemination these recommendations and materials to the health plans involved in this project.
*Note: These projects are based and administered by other HFHS Departments, but are staffed by a CHSR Co-investigator(s).
ONGOING FUNDED PROJECTS
PI: Daniel Newman, M.D., Co-Investigator: David R. Nerenz, Ph.D. Methods for Estimating the Incidence and Prevalence of Amyotrophic Lateral Sclerosis in the U.S. Population. CDC 2008-2010 ($194,743)**
Site P.I.: Jennifer Elston Lafata, Ph.D. Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics (Part II). CDC/Battelle Seattle Research Center 2008-2011 ($265,642)
Site P.I.: Jennifer Elston Lafata, Ph.D. Evaluating a Preference-Tailored Intervention for Increasing Colorectal Cancer Screening. NIH 2008-2012 ($534,938)
P.I.: David Lanfear, MD. Renal Function, Treatment Patterns, Resource Utilization and Outcomes in Acute Decompensated Heart Failure Patients Admitted in Hospital. Merck 2008-2009 ($239,460)
Site PI: David Nerenz, Ph.D. CANCORS. Dana Farber Institute 2008-2009 ($105,000)
Site P.I.: Jennifer Elston Lafata, Ph.D. Focusing Implementation to Bring Effective Reminders (FIBER). NCI 2008-2012 ($129,011)
P.I.: Jennifer Elston Lafata, Ph.D. Physician Recommendation and Colorectal Cancer Screening. NCI 2006-2010 ($1,607,623)
Site P.I.: Jennifer Elston Lafata, Ph.D. Medical Care Burden of Cancer: System and Data Issues. NIH. 2007-2010 ($489,129)
Site P.I.: Jennifer Elston Lafata, Ph.D. Medication Use and Cost for Adult Cancer Patients. NIH. 2007-2010 ($78,611)
P.I.: Jennifer Elston Lafata, Ph.D. The Impact of Diabetes Control on Employment and Work. NIDDK. 2007-2009 ($387,300)
P.I.: Stanton Elias, Co-Investigator: Jennifer Elston Lafata, Ph.D. Adherence to Disease Modifying Agents among Patients with Multiple Sclerosis. TEVA Neuroscience 2005-2009 ($562,877)**
P.I.: Jennifer Elston Lafata, Ph.D. Oral Antidiabetic and Insulin Use among Patients with Diabetes. Sanofi-Aventis 2005-2008 ($400,000)
P.I.: David Nerenz, Ph.D. Reanalyzing Data Sets using Path Analysis & Structured Equation Modeling to Reduce Racial/Ethnic Health Care Disparity. RWJ. 2007-2008 ($73,100)
P.I.: Manel Pladevall, MD. MSc. The Clinical Effectiveness of Pharmacy Adherence Information for Diabetes Control. NIH. 2006-2011 ($1,632,238)
P.I: L. Keoki Williams, MD, MPH. Using Information Technology to Improve Asthma Adherence. NIAID 2005-2009 ($1,431,091).
P.I: L. Keoki Williams, MD, MPH. Mechanism of Endotoxin’s Effect on Allergy Risk. NIAID 2004-2009 ($3,031,295)**
**Note: These projects are administered by other HFHS Departments, but are staffed by a CHSR Investigator or Co-Investigator(s). PUBLICATIONS Elston Lafata J, Cerghet M, Dobie E, Schultz L, Tunceli K, Reuther J, Elias S. Measuring Adherence and Persistence to Disease Modifying Agents among Patients with Relapsing Remitting Multiple Sclerosis. Journal of the American Pharmacist Association 2008 Nov/Dec;48(6):752-7 (http://www.ncbi.nlm.nih.gov/pubmed/19019804) Heisler M, Hogan MM, Hofer TP, Schmittdiel JA, Pladevall M, Kerr EA. When More Is Not Better: Treatment Intensification Among Hypertensive Patients With Poor Medication Adherence. Circulation 2008 June 3;117(22):2884-92
Lieu TA, Ortega-Sanchez I, Ray GT, Rusinak D, Yih WK, Choo PW, Shui I, Kleinman K, Harpaz R, Prosser LA. Community and patient values for preventing zoster. Pharmacoeconomics
Naqvi M, Tcheurekdjian H, DeBoard JA, Williams LK, Navarro D, Castro RA, Rodriguez-Santana JR, Chapela R, Watson HG, Meade K, Rodriguez-Cintron W, LeNoir M, Thyne SM, Avila PC, Choudhry S, González Burchard E. Inhaled corticosteroids and augmented bronchodilator responsiveness in Latino and African American asthmatic patients. Ann Allergy Asthma Immunol 2008 Jun;100(6):551-7.
Paris J, Peterson EL, Wells K, Pladevall M, Burchard EG, Choudhry S, Lanfear DE, Williams LK. Relationship between recent short-acting β-agonist use and subsequent asthma exacerbations. Ann Allergy Asthma Immunol 2008 Nov;101(5):482-7.
Prosser LA, O’Brien MA, Molinari NA, Hohman KH, Nichol KL, Wortley PM, Messonnier ML, Lieu TA. Cost-effectiveness of delivering adult influenza vaccination in non-traditional settings. Pharmacoeconomics 2008;26(2):163-178
Prosser LA, Kong J, Rusinak D, Waisbren SE. Waisbren. Expanded newborn screening: the effect of preferences for false positive test results and dietary treatments on cost-effectiveness. Med Decis Making 2008;25(1):E60
Prosser LA, Ladapo JA, Rusinak D, Waisbren SE. Parental tolerance for false-positive newborn screening results. Arch Pediatr Adolesc Med
Sandberg EA, Prosser LA, Neumann P, Weinstein MC. Health state utilities in children ages 7-10 with attention deficit hyperactivity disorder. Med Decis Making 2008;25(1):E72
Seibold MA, Wang B, Eng C, Kumar G, Beckman KB, Sen S, Choudhry S, Meade K, Lenoir M, Watson HG, Thyne S, Williams LK, Kumar R, Weiss KB, Grammer LC, Avila PC, Schleimer RP, Burchard EG, Brenner R. An African-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity. Hum Mol Genet 2008 Sep 1;17(17):2681-90. Epub 2008 Jun 4.
Tunceli K, Zeng H, Habib ZA, Williams LK. Long-term projections for diabetes-related work loss and limitations among U.S. adults. Diabetes Res Clin Pract 2009 Jan;83(1):e23-5. Epub 2008 Dec 16.
Wells K, Pladevall M, Peterson EL, Campbell J, Wang M, Lanfear DE, Williams LK. Race-ethnic Differences in Factors Associated with Inhaled Steroid Adherence Among Adult Asthmatics. Am J Respir Crit Care Med 2008 Dec 15;178(12):1194-201. Epub 2008 Oct 10.
Williams LK, Oliver J, Peterson EL, Bobbit KR, McCabe MJ, Smolarek D, Havstad SL, Wegienka G, Burchard EG, Ownby DR, Johnson CC. Gene-environment interactions between CD14 C-260T and endotoxin exposure on Foxp3+ and Foxp3- CD4+ lymphocyte numbers and total serum IgE levels in early childhood. Ann Allergy Asthma Immunol 2008;100(2):128-136
Yang JJ, Burchard EG, Choudhry S, Johnson CC, Ownby DR, Favro D, Chen J, Akana M, Ha C, Kwok PY, Krajenta R, Havstad SL, Joseph CL, Seibold MA, Shriver MD, Williams LK. Differences in allergic sensitization by self-reported race and genetic ancestry. J Allergy Clin Immunol 2008 Oct;122(4):820-827.e9. Accepted for Publication [In Press] Cresci S, Jones PG, Marsh S, Lanfear DE, Garsa A, Courtois M, Weinheimer CJ, Kelly DP, McLeod HL, Spertus JA. Interaction Between PPARA Genotype and β-Blocker Treatment Influences Clinical Outcomes Following Acute Coronary Syndromes. Pharmacogenomics
Jaffery Z, Nowak R, Khoury N, Tokarski G, Lanfear DE, Jacobson G, McCord J, Myoglobin and Troponin I Elevation Predict 5 year mortality in Patients with Undifferentiated Chest Pain in the Emergency Department. Am Heart J
Russman A, Silver B, Mitsias P, Schultz L, Zaman I, Rehman M, Nerenz DR. A Significant Temporal and Quantitative Relationship Exists Between High-Density Lipoprotein Levels and Acute Ischemic Stroke Presentation. Journal of the Neurological Sciences
Williams G, Patrick H, Niemiec CP, Williams LK, Divine G, Elston Lafata J, Heisler M, Tunceli K, Pladevall M. Reducing the Health Risks of Diabetes: How Self-determination Theory May Help Improve Medication Adherence and Quality of Life. Diabetes Educator
Under Revision
Tunceli O, Elston Lafata J, Green-Edwards C, Joseph CLM. The Impact of a Tailored Asthma Education Program for Urban Adolescents on Medical Care Utilization and Costs. Journal of Urban Health
Tunceli O, Cerghet M, Lipton RB, Elston Lafata J. The Use of Migraine Preventive Medications among Patients with and without Migraine Headaches. Cephalalgia
Elston Lafata J, Dobie E, Divine G, Ulcickas Yood M, McCarthy B. Prolonged Hyperglycemia among Patients with Diabetes: What Matters When Action is Needed? Diabetes Care
Submitted for Publication Cerghet M, Dobie E, Lafata JE, Schultz L, Elias S, Reuther J, Pladevall M, Yang N. Adherence to Disease Modifying Agents in Multiple Sclerosis and Association with Patient Outcomes and Cost of Care. American Journal of Managed Care
Rosenblum ML, Kalkanis S, Goldberg W, Rock J, Mikkelsen T, Remer S, Whitehouse S, Nerenz DR. Odyssey of Hope: A Physician’s Guide to Communicating with Brain Tumor Patients Across the Continuum of Care. Journal of Neuro-Oncology
Salz T, Weinberger M, Ayanian J, Brewer NT, Cooper GS, Earle GS, Lafata JE, Fisher DA, Mandelson MT, Weiner BJ, Sandler RS. Variation in the use of Surveillance Colonoscopy among Survivors of Colorectal Cancer. Cancer
Nerenz DR, Woods B, Wisdom K. The role of private purchasers in reducing racial and ethnic disparities in health care: Improving breast cancer screening among African American women. Joint commission Journal of Quality and Patient Safety
Nerenz DR. Ethnical issues in using data from quality management programs. European Spine Journal
PRESENTATIONS
Ownby DR, Peterson EL, Joseph CLM, Williams LK, Woodcroft KJ, Wegienka G, Johnson CC. The Development of Anti-tetanus IgE Antibodies in the First 2 years of Life. American Academy of Allergy, Asthma & Immunology. Philadelphia, PA, March 14-18, 2008
Johnson CC, Wegienka GR, Havstad SL, Persky VW, Joseph CL, Woodcroft KJ, Zoratti EM, Peterson EL, Bobbitt KR, Williams LK, Ownby DR. Prenatal Exposure to Acetaminophen in Relationship to Total IgE at Birth, Six Months and Two Years of Age. American Academy of Allergy, Asthma & Immunology. Philadelphia, PA, March 14-18, 2008
Woodcroft KJ, Havstad S, Smolarek DM, Bobbitt KR, Williams K, Joseph CL, Wegeinka GR, Ownby DR, Johnson CC. Th2/Th1 Intracellular Cytokine Profiles in African American and Caucasian Infants in the First Year of Life. American Academy of Allergy, Asthma & Immunology. Philadelphia, PA, March 14-18, 2008
Weinstein AG, Lee B, Williams K. The Relationship between Adherence Monitoring and Study Efficacy in ICS Trials. American Academy of Allergy, Asthma & Immunology. Philadelphia, PA, March 14-18, 2008
Lafata JE. Appropriate Care Receipt among Patieints with Hyperglycemia: What Matters When Action is Needed? 14th Annual HMO Research Network Conference, Minneapolis, MN, April 13-16, 2008
Nerenz DR, Liu Y, Tunceli K, Zeng H. A Business Care for Eliminating Racial/Ethnic Disparities in Health Care - Employer Perspective. 14th Annual HMO Research Network Conference, Minneapolis, MN, April 13-16, 2008
Lafata JE, Dobie E, Divine G, McCarthy BD, Ulcickas Yood M. Factors Associated with Continued Inertia among Patients with Diabetes. 14th Annual HMO Research Network Conference, Minneapolis, MN, April 13-16, 2008
Elston Lafata J, Cooper G, Divine G, Flocke W, Siminoff L, Stange K, Wunderlich T. The Content of Physician-Patient Discussions during Routine Health. 14th Annual HMO Research Network Conference. Minneapolis, MN, April 13-16, 2008 [poster]
Cerghet M, Dobie E, Schultz L, Tunceli K, Elias S, Reuther J, Pladevall M, Elston Lafata J. The Associations of Medication Adherence with Employment and Work Disability among Patients with Relapsing Remitting Multiple Sclerosis. 14th Annual HMO Research Network Conference. Minneapolis, MN, April 13-16, 2008 [poster]
Amin B, Krishnamurthy S, Nerenz DR, Malik G. Does Race Matter in Predicting Aneurysm Rupture? 76th Annual Meeting of the American Association of Neurological Surgeons. Chicago, IL April 26-May1, 2008 [poster]
Nerenz DR, Bennett J, Liang J, Elston Lafata J, Neslund-Dudas C. Path Analysis as a Method for Analyzing Racial/ethnic Ddisparities in Treatment Outcomes. 5th Annual Research Symposium HFMG Academic Affairs, Henry Ford Health System. Detroit, MI, March 14, 2008 [poster]
Cerghet M, Dobie E, Schultz L, Tunceli K, Elias S, Reuther J, Pladevall M, Elsotn Lafata J. The Association of Medication Adherence with Health and Economic Outcomes among Patients with Relapsing Remitting Multiple Sclerosis. 5th Annual Research Symposium HFMG Academic Affairs, Henry Ford Health System. Detroit, MI, March 14, 2008 [poster]
Elston Lafata J, Cooper G, Divine G, Flocke S, Siminoff L, Simpkins J, Stange K, Wunderlich T. The Content of Physician-Patient Discussions during Routine Health Maintenance Exams. 5th Annual Research Symposium HFMG Academic Affairs, Henry Ford Health System, March 14, 2008, Detroit, MI [poster]
Cerghet M, Schultz L, Dobie E, Reuther J, Elias J, Elston Lafata J. Racial Disparities in Adherence to Disease Modifying Agents and Quality of Life in Patient with Multiple Sclerosis. World Congress on Treatment and Research in Multiple Sclerosis. Montreal Quebec Canada, September 18, 2008 [poster]
Lavelle TA, Uyeki TM, Prosser LA. The Impact of Pediatric Adverse Events on the Cost-effectiveness of Oseltamivir. 13th Annual International Meeting, International Society for Pharmacoeconomics and Outcomes Research. Toronto, ON, Canada, May 4, 2008
Wright DR, Wittenberg E, Swan JS, Miksad R, Prosser LA. A Review and Critique of Methods for Measuring Temporary Health States in Cost-utility Analyses. 13th Annual International Meeting, International Society for Pharmacoeconomics and Outcomes Research. Toronto, ON, Canada, May 5, 2008
Nerenz DR, Bennet J, Liang J, Elston Lafata J. Path Analysis as an Approach to Understanding Racial/ethnic Disparities in Health Care. 25th Annual AcademyHealth Conference (joing HMORN-BCBSA session). Washington DC, June 7, 2008
Nerenz DR. Building Bridges between Researchers and Managers – Can it be done? 2nd AHRQ Annual Conference, Bethesda, MD, September 8, 2008
Nerenz DR. Adressing Racial/ethnic Disparities in Quality of Ccare. Keynote Speaker. AHIP Medicaid Conference, Washington DC, September 25, 2008
Elston Lafata J, Dobie E, Divine G, Ulcickas Yood M, McCarthy, B. Factors Associated with Receipt of Appropriate Care among Patients with a Prolonged and Persistent Period of Hyperglycemia: What matters when action is needed? European Association for the Study of Diabetes. Rome, Italy, September 7-11, 2008 [poster]
Elston Lafata J, Divine G, Dobie E, McCarthy BD, Yang N, Ulcickas Yood M. Patient-reported Content of Diabetes Treatment Discussions with Physicians and Glycemic Control. 30th Annual Meeting of the Society for Medical Decision Making. Philadelphia, PA, October 19-22, 2008 [poster]
Elston Lafata J, Cooper G, Divine G, Flocke S, Siminoff L, Simpkins J, Stange K, Wunderlich T. Coloectal Cancer Screening Recommendations in Primary Care. 30th Annual Meeting of the Society for Medical Decision Making. 30th Annual Meeting of the Society for Medical Decision Making. Philadelphia, PA, October 19-22, 2008 [poster] Wunderlich T, Cooper G, Divine G, Flocke S, Siminoff L, Stange K, Elston Lafata J. Concordance of Patient-reported Decision Making Preferences and Processes Used during Physical Exams. 30th Annual Meeting of the Society for Medical Decision Making. Philadelphia, PA, October 19-22, 2008 [poster]
Nerenz DR. Translating Research Into Practice (TRIP). Presented at the Ob/Gyn Department Grand Rounds. St. Joseph Mercy Hospital, Ann Arbor, MI, October 30, 2008
Al-Mallah M, Alqaisi F, Nerenz DR, Boedeker S, Weaver WD. Does a Public Smoking Ban Reduce the Incidence of Myocardial Infaraction in Michigan? A Systematic Review and Attributable Risk Analysis. Annual Meeting of the American Heart Association. New Orleans, LA, November 11, 2008
Nerenz DR. Translating Research into Practice (TRIP). Southeast Michigan Council for Medical Education Annual Research Seminar, Southfield, MI, November 19, 2008 Dave.MD (http://dave.md/s/index/cfm?aid=1258). “Uncontrolled Diabetes Correlates with Lost Workdays.” (Tunceli K, Bradley CJ, Elston Lafata J, Pladevall M, Goodman AC, Divine G, Vijan S) Committees HFHS Committees
External Committees
Reviewers
Editorial Boards
STAFF RECRUITMENT
CONTINUING ADJUNCT APPOINTMENTS
Photo: HFH Ambulance, 1930
Conrad R. Lam Archives http://www.henryford.com/body_nologin.cfm?id=39480
|
|||||||
